These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21717820)

  • 1. Comparative effectiveness research: does the emperor have clothes?
    Coulter ID
    Altern Ther Health Med; 2011; 17(2):8-15. PubMed ID: 21717820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effectiveness research: a progress report.
    Sox HC
    Ann Intern Med; 2010 Oct; 153(7):469-72. PubMed ID: 20679544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Science and the stiumulus. Medicine under the microscope.
    Marshall E
    Science; 2009 Nov; 326(5957):1183-5. PubMed ID: 19965447
    [No Abstract]   [Full Text] [Related]  

  • 4. An evaluation of recent federal spending on comparative effectiveness research: priorities, gaps, and next steps.
    Benner JS; Morrison MR; Karnes EK; Kocot SL; McClellan M
    Health Aff (Millwood); 2010 Oct; 29(10):1768-76. PubMed ID: 20921474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How a unique provision in the American Recovery and Reinvestment Act set a foundation for the Patient-Centered Outcomes Research Institute.
    Selby J; Slutsky J
    J Comp Eff Res; 2014 Nov; 3(6):565-6. PubMed ID: 25494560
    [No Abstract]   [Full Text] [Related]  

  • 6. Lessons from comparative effectiveness research methods development projects funded under the Recovery Act.
    Zurovac J; Esposito D
    J Comp Eff Res; 2014 Nov; 3(6):601-7. PubMed ID: 25494566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ARRA investment in CER: a description of the midstream evaluation and how the funds were allocated and CER priorities addressed.
    Esposito D; Yong PL; Rich E; Geonnotti K; Kimmey LD
    J Comp Eff Res; 2014 Nov; 3(6):581-9. PubMed ID: 25494564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of comparative effectiveness on U.S. healthcare providers.
    Bigalke JT
    Healthc Financ Manage; 2009 Oct; 63(10):74-8. PubMed ID: 19810656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The American Reinvestment and Recovery Act investment in comparative effectiveness research: lessons learned and implications for future investments.
    Dormer L; Greenfield S
    J Comp Eff Res; 2014 Nov; 3(6):559. PubMed ID: 25494558
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessing the long-term impact of public investments in comparative effectiveness research: conceptual framework and lessons learned.
    Rich EC; Esposito D; Kimmey LD; Valenzano CS; Yong PL
    J Comp Eff Res; 2014 Nov; 3(6):657-66. PubMed ID: 25494572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spending limited health care dollars on what works best: the promise of comparative effectiveness research.
    Stein J
    N C Med J; 2010; 71(3):265-6. PubMed ID: 20681501
    [No Abstract]   [Full Text] [Related]  

  • 12. Science and the stimulus. Science and the stimulus.
    Mervis J
    Science; 2009 Nov; 326(5957):1176-7. PubMed ID: 19965443
    [No Abstract]   [Full Text] [Related]  

  • 13. Research funding. Health bill backs evidence-based medicine, new drug studies.
    Kaiser J
    Science; 2010 Mar; 327(5973):1562. PubMed ID: 20339036
    [No Abstract]   [Full Text] [Related]  

  • 14. American Recovery and Reinvestment Act investments in data infrastructure.
    O'Day B; Kieffer T; Forrestal S; Esposito D
    J Comp Eff Res; 2014 Nov; 3(6):591-600. PubMed ID: 25494565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Building sustainable multi-functional prospective electronic clinical data systems.
    Randhawa GS; Slutsky JR
    Med Care; 2012 Jul; 50 Suppl():S3-6. PubMed ID: 22692255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invited article: comparative effectiveness research, evidence-based medicine, and the AAN.
    French JA; England JD
    Neurology; 2010 Aug; 75(6):562-7. PubMed ID: 20697109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of rigorous scientific evaluation in the use and practice of complementary and alternative medicine.
    Kantor M
    J Am Coll Radiol; 2009 Apr; 6(4):254-62. PubMed ID: 19327658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effectiveness research (CER): a summary of AHRQ's CER on therapies for rheumatoid arthritis.
    Oderda GM; Balfe LM
    J Manag Care Pharm; 2011; 17(9 Suppl B):S19-24. PubMed ID: 22073936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The past, present, and future of comparative effectiveness research in the US Department of Veterans Affairs.
    Kupersmith J; Ommaya AK
    Am J Med; 2010 Dec; 123(12 Suppl 1):e3-7. PubMed ID: 21184864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of comparative effectiveness research on interventional pain management: evolution from Medicare Modernization Act to Patient Protection and Affordable Care Act and the Patient-Centered Outcomes Research Institute.
    Manchikanti L; Falco FJ; Benyamin RM; Helm S; Parr AT; Hirsch JA
    Pain Physician; 2011; 14(3):E249-82. PubMed ID: 21587337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.